Primary Immune Deficiency
Top in allergy/asthma: Epinephrine autoinjectors lack benefits; rhinitis and mental health
Epinephrine autoinjectors may have limited effectiveness in helping patients survive anaphylaxis events, according to a review published in Clinical and Experimental Allergy.
Q&A: Video series educates physicians about primary immunodeficiencies
Patients with primary immunodeficiencies experience an average of 9 to 15 years between the onset of their symptoms to diagnosis of their disorder and treatment that could save their lives, according to the Immune Deficiency Foundation.
Top news of April: Tree nut oral immunotherapy, asthma care in prison, more
Healio compiled the most-read news in allergy, asthma and immunology posted in April.
Maternal primary immunodeficiency linked to offspring’s psychiatric disorders, suicidality
Children born to mothers, not fathers, with primary antibody immunodeficiencies had greater risks for certain psychiatric disorders and for suicidal behavior, according to data published in JAMA Psychiatry.
Q&A: Awareness essential to diagnosis, treatment of rare primary immunodeficiency
Warts, hypogammaglobulinemia, infections and myelokathexis — or WHIM — syndrome is a rare but important primary immunodeficiency that leaves some patients susceptible to life-threatening infections as well as to cancer.
Primary humoral immunodeficiencies linked to psychiatric disorders, suicidal behavior
Primary humoral immunodeficiencies appeared significantly associated with psychiatric disorders and suicidal behavior, according to study results published in JAMA Psychiatry.
Patient-centered care ideal for primary immune deficiencies
HOUSTON — Primary immune deficiencies affect approximately 500,000 people in the United States, according to the National Institute of Allergy and Infectious Diseases.